AGP Limited (PSX:AGP)

Market Cap	61.80B
Revenue (ttm)	27.73B
Net Income (ttm)	3.69B
Shares Out	280.00M
EPS (ttm)	13.19
PE Ratio	16.73
Forward PE	13.23
Dividend	4.00 (1.86%)
Ex-Dividend Date	Sep 2, 2025

Volume	187,015
Average Volume	291,742
Open	213.15
Previous Close	215.14
Day's Range	213.15 - 224.00
52-Week Range	142.00 - 229.89
Beta	0.27
RSI	68.25
Earnings Date	Feb 26, 2026

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.